Cough Evaluation and Management in Adults: A Clinical Guide for Doctors

Effective cough evaluation and management remain a cornerstone of clinical practice, accounting for approximately 30 million annual clinician visits in the United States. While frequently a self-limited manifestation of viral upper respiratory infections, a persistent cough can constitute up to 40% of outpatient pulmonary practice volume. 

The clinical challenge for the modern practitioner lies in utilizing a systematic, evidence-based diagnostic pathway to distinguish routine post-infectious cases from life-threatening malignancies or refractory chronic pathologies—such as Cough Hypersensitivity Syndrome—that significantly impair patient quality of life.

1. Defining Cough: Classification by Duration

Cough is a reflex explosive expiration intended to clear secretions and foreign particles from the respiratory tract. Clinically, the most robust method for narrowing the differential diagnosis is classification by duration: Acute (<3 weeks), Subacute (3–8 weeks), and Chronic (>8 weeks).

2. Pathophysiology: The Cough Reflex Arc

The cough reflex is mediated by a complex arc initiated by the irritation of mechanical and chemical receptors (specifically TRPV1 and TRPA1 ion channels) in the epithelium of the respiratory tract, esophagus, pericardium, and diaphragm.

• Afferent Pathway: Impulses traverse the vagus nerve to the "cough center" in the medulla.
• Efferent Pathway: Signals descend via the vagus, phrenic, and spinal motor nerves to the expiratory musculature.
• Sex-Based Dimorphism: Women exhibit significantly heightened cough reflex sensitivity and are more frequently represented in the chronic cough cohorts.

3. Initial Clinical Assessment and History

3.1. Key History

Obtain focused history, including:

• Duration and progression
• Dry vs productive cough
• Daytime vs nocturnal predominance
• Fever, wheeze, dyspnea, chest pain
• Hemoptysis
• Smoking/vaping exposure
• Occupational dust or chemical exposure
• Medication history (especially ACE inhibitors)
• Reflux symptoms
• Rhinitis/postnasal drip symptoms
• Weight loss or anorexia
• Travel or TB exposure
• Immunosuppression

3.2 Physical Examination and Sputum Character

Clinicians should perform a directed examination:

4. Red Flags Requiring Urgent Evaluation

Immediate imaging or specialist assessment is warranted with:

• Hemoptysis
• Hypoxemia
• Respiratory distress
• Weight loss
• Persistent fever
• Hoarseness
• Dysphagia
• Recurrent pneumonia
• Immunocompromised state
• Abnormal lung exam
• Smoking history with persistent cough
• Suspected pulmonary embolism
• Hoarseness/Dysphonia: May indicate laryngeal malignancy or Laryngopharyngeal Reflux (LPR).
• Sudden Onset of Violent Coughing: Suspected foreign body inhalation.

5. Differential Diagnosis by Duration

5.1 Acute Cough

Most common causes:

• Viral upper respiratory infection
• Acute bronchitis
• COVID-19 / influenza
• Pneumonia
• Asthma exacerbation
• COPD exacerbation
• Pulmonary embolism
• Heart failure

If uncomplicated viral syndrome: supportive care only.

If fever, tachypnea, hypoxia, focal crackles, pleuritic pain:

• Chest X-ray
• CBC if indicated
• Viral testing when it is clinically useful

5.2 Chronic Cough (>8 Weeks): The "Big Three" and Beyond

In non-smokers with normal imaging, nearly 90% of cases are due to Upper Airway Cough Syndrome (UACS), asthma, or GERD.

• UACS: Characterized by frequent throat clearing, nasal discharge, and "cobblestoning" of the mucosa.
• GERD vs. LPR: GERD typically involves recumbent symptoms, heartburn, and Lower Esophageal Sphincter (LES) dysfunction. In contrast, Laryngopharyngeal Reflux (LPR) is often an upright, Upper Esophageal Sphincter (UES) problem presenting with dysphonia, throat clearing, and arytenoid erythema/edema.

Other important causes:

• Nonasthmatic eosinophilic bronchitis (NAEB)
• COPD
• Bronchiectasis
• Interstitial lung disease
• Lung cancer
• Tuberculosis
• ACE inhibitor use
• Chronic aspiration
• Heart failure

6. Systematic Chronic Cough Evaluation and Management

Diagnostic clarity is maintained by a sequential approach—testing or treating for one etiology at a time—unless the cough is disabling.

6.1. Stepwise Diagnostic Algorithm

6.2. Diagnostic Tools

• Chest X-ray (CXR): First-line for all chronic cough.
• Spirometry: Assesses for reversible airflow obstruction.
• Methacholine Challenge: Most valuable for its high negative predictive value; a negative result effectively rules out asthma.
• Sputum Eosinophilia: Essential for diagnosing Non-Asthmatic Eosinophilic Bronchitis (NAEB) in the absence of airway hyperresponsiveness.

6.3. Management of Common Etiologies

• UACS: First-generation antihistamine-decongestant combinations (e.g., brompheniramine/pseudoephedrine) are superior to second-generation agents due to their potent anticholinergic effects.
• Asthma: Inhaled GCs and as-needed bronchodilators; LTRAs are alternatives.
• GERD/LPR: Requires lifestyle modifications and a minimum 8-week trial of PPIs (e.g., omeprazole 40 mg) to allow for mucosal healing and reflex normalization.
• ACE Inhibitor-Induced Cough: Discontinue the agent; transition to ARBs.
• NAEB: Responds to inhaled GCs; requires confirmation via sputum eosinophilia.

6.4. Refractory Chronic Cough: Management of the Unexplained

For cases involving "Cough Hypersensitivity Syndrome," quantify quality of life using the Leicester Cough Questionnaire (LCQ) and consider neuromodulators.

• Gabapentin: Titrated up to 1800 mg/day.
• Pregabalin: 300 mg/day.
• Non-Pharmacological: Speech Pathology Treatment (SPT) and cough-suppression techniques.

7. Clinical Pearls and Conclusion

• The 4-Month Rule: While the ACEI cough typically resolves in 1–4 weeks, it can occasionally persist for up to four months after drug cessation.
• Reflux is "Silent": Over 40% of patients with GERD/LPR-related cough lack traditional heartburn symptoms.
• Antibiotic Stewardship: Macrolides for pertussis provide little benefit if started >2 weeks into the clinical course.

Conclusion: A systematic cough evaluation and management strategy prioritizes sequential diagnostic trials over simultaneous "shotgun" testing. This approach effectively identifies the underlying pathology in 75–90% of cases, mitigating patient morbidity and unnecessary healthcare expenditure.

8. FAQs

1. How long does the ACE inhibitor cough take to resolve? Usually 1–4 weeks, though the summary of evidence notes it may occasionally take up to 4 months.
2. Is a normal CXR sufficient to rule out lung cancer in a heavy smoker? No. A CT thorax is indicated if clinical suspicion is high or the cough character changes.
3. Why use first-generation antihistamines for UACS? Their strong anticholinergic effect is required to reduce the secretions that stimulate the laryngeal cough receptors.
4. When should I order a methacholine challenge? To rule out asthma when baseline spirometry is normal but suspicion remains high (utilizing its negative predictive value).
5. How long is the trial for PPIs in GERD with cough? At least 8 weeks for a definitive diagnostic/therapeutic trial.
6. What is the role of FeNO? Exhaled nitric oxide can correlate with sputum eosinophilia and predict glucocorticoid response in asthma and NAEB.
7. Can Arnold's nerve cause a cough? Yes. Irritation of the auricular branch of the vagus nerve (usually by cerumen or foreign bodies in the ear) can trigger a dry cough; PVCs are a much rarer cause.
8. What is the LCQ? The Leicester Cough Questionnaire is a validated tool to quantify cough-specific quality of life, particularly in refractory cases.

9. References